Changes to diagnostic criteria in MS to improve speed and accuracy of diagnosis

20 July, 2018 | Posted in:

Experts in multiple sclerosis (MS) have recently recommended changes to the widely used diagnostic criteria for the condition. The McDonald criteria, first published in 2010, allows diagnosis of MS after one relapse, if an MRI imaging scan shows evidence of damage to the brain through lesions developing. Lately experts have gathered to review the criteria, […]

Continue Reading »

2018 MS MasterClass 3 winners announced

8 June, 2018 | Posted in:

Last night, the winners of the 2018 MS MasterClass intermodule delegate projects were announced. Dr Rachel Dorsey-Campbell was voted winner by her peer group and faculty for implementing a pharmacy-led prescribing and monitoring service for natalizumab. Her research found that the new service resulted in better monitoring of patient health when being treated, making the […]

Continue Reading »

GIRFT (Get it Right First Time) – Parkinson’s and MS services to be reviewed in National Census

31 May, 2018 | Posted in:

Following the successful completion of a quality improvement pilot in orthopaedic surgery entitled Getting It Right First Time (GIRFT), the Department of Health and NHS Improvement (NHSI) have commissioned an expansion of the GIRFT programme that will cover an additional 35 clinical areas over four years from April 2017 to support providers in delivering clinical […]

Continue Reading »

Debate on the NHS England algorithm for MS treatment by disease-modifying drugs

15 May, 2018 | Posted in:

The Neurology Academy hosted a debate at the ICC Birmingham this year to discuss the newly proposed NHS England algorithm for using disease-modifying treatments (DMTs) to manage multiple sclerosis (MS). We interviewed a number of key people at the debate on 9th May to help get a clearer and fuller picture of what this algorithm […]

Continue Reading »

Preparing for the General Data Protection Regulation (GDPR)

3 May, 2018 | Posted in:

You may have heard about the EU’s new privacy law General Data Protection Regulation (GDPR). Sarah Gillett, the Neurology Academy’s Managing Director, has been talking to Toby Foster this morning on BBC Radio Sheffield about what the Academy does to comply with upcoming legislation. You can listen to the interview about the GDPR here. (Source: BBC […]

Continue Reading »

Invitation to an evening debate on 9 May

25 April, 2018 | Posted in:

You may be aware of the new ‘Recommendations for an NHS England algorithm to use disease-modifying drugs to treat Multiple Sclerosis’ is currently out for public consultation. The algorithm raises several issues for clinical practice. We are hosting an evening dinner in the ICC where the Association of British Neurologists (ABN) is being held, on […]

Continue Reading »

Fingolimod safety considerations in real world practice – Assessing screening for macular oedema

5 February, 2018 | Posted in:

Dr Paul Gallagher and Dr Sarah-Jane Martin from the Institute of Neurological Sciences in Glasgow undertook their MS Masterclass project to understand if patients in their Centre on Fingolimod were adequately screened for macular oedema. Fingolimod is a first in class sphingosine-1 phosphate (S1P) receptor modulator and was the first oral DMT licensed for use […]

Continue Reading »